Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification
John Amara, Ph.D. and Michael Dullen Merck, 80 Ashby Road, Bedford, MA, 01730, USA
Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities with Disposable Technologies
Gloria Gadea-Lopez, Ph.D. is Director of Production and Business Systems at the Shire Lexington, John Maguireis the Associate Director of Manufacturing Systems at Shire’s Lexington and Megan Rabideau is a Manufacturing Systems Engineer at Shire’s Lexington
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Headline News
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
mNEXSPIKE associated with lower COVID-19 hospitalisation risk than Comirnaty in older adults
Pasritamig combination delivers 73% PSA response rate in advanced prostate cancer Phase I study
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing
Presented by Clive Glover, PhD, Senior Marketing Manager, Cell & Gene Therapy at Pall and Rachel Legmann, PhD, Senior Manager, Process Development Services at Pall
13th November 2018
Strategies to overcome Low Endotoxin Recovery using the conventional LAL assay
Presented by Dr. Ruth Daniels, Janssen & Kevin L. Williams, BIOMÉRIEUX
28th June 2018
Challenges and Successes in Externalization of the ADC Supply Chain
Presented by Firelli Alonso, Ph.D., Pfizer
14th February 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Push-Button Simplicity: Automatic Fermentation with the BioFlo® 120 Auto Culture Mode
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
